Table 1.
Baseline Characteristics
| Characteristic | Incident MI (N=892) | No MI (N=19 131) |
|---|---|---|
| Demographics, n (%) | ||
| Age | ||
| Median, y (25th, 75th) | 62 (54, 70) | 60 (52, 67) |
| ≥75 y | 139 (15.6) | 1699 (8.9) |
| Female | 214 (24.0) | 4123 (21.6) |
| White race | 785 (88.0) | 16 951 (88.7) |
| Qualifying atherosclerosis, n (%) | ||
| Myocardial infarction | 749 (84.0) | 16 018 (83.7) |
| Peripheral arterial disease | 143 (16.0) | 3113 (16.3) |
| Clinical characteristics, n (%) | ||
| Diabetes mellitus | 324 (36.3) | 4392 (23.0) |
| Hypertension | 687 (77.1) | 12 291 (64.2) |
| Hyperlipidemia | 811 (90.9) | 16 192 (84.6) |
| Current smoker | 226 (25.3) | 4103 (21.4) |
| Previous coronary revascularization | 738 (82.7) | 15 049 (78.7) |
| Congestive heart failure | 162 (18.2) | 1547 (8.1) |
| Antiplatelet agents at randomization, n (%) | ||
| Thienopyridine | 684 (76.7) | 13 594 (71.1) |
| Aspirin | 853 (95.6) | 18 508 (96.7) |
MI indicates myocardial infarction.